SCHEMBL1983234

SCHEMBL1983234

Cc1ccc(Cl)c2c(O)c(C(=O)O)c(=O)[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
DPP4 P27487 1/20 0.42
ADRA2A P08913 1/20 0.40
CLCN2 P51788 1/20 0.40
MET P08581 4/20 0.39
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
RNASEH1 O60930 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35
DAO P14920 1/20 0.35
DDO Q99489 1/20 0.35
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16098758 0.85 USP2 (0.44) MEN1NPC1RAB9AKMT2AMET
SCHEMBL1986500 0.82 LMNA (0.48) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14335694 0.80 CYP19A1 (0.42) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL1982721 0.78 TP53 (0.46) MEN1NPC1RAB9AKMT2AALDH1A1
SCHEMBL3359777 0.77 MEN1 (0.43) MEN1NPC1RAB9AKMT2AADRA2A
SCHEMBL1033282 0.77 GRIN2D (0.43) MEN1KMT2ADPP4KDM4E
SCHEMBL5809605 0.73 RPA1 (0.49) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL8321684 0.72 MEN1 (0.43) MEN1NPC1RAB9AKMT2AADRA2A
SCHEMBL2483507 0.71 KDM4E (0.50) NPC1RAB9AKMT2ACYP3A4KDM4E
SCHEMBL28759223 0.70 DPP4 (0.69) MEN1KMT2ADPP4CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970129-A2 CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF Teva Pharmaceutical Industries Ltd. (IL) 2016-01-20 EP claimed
WO-2014153145-A2 CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2014-09-25 WO claimed
EP-2970129-A2 CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF Teva Pharmaceutical Industries Ltd. (IL) 2016-01-20 EP disclosed
WO-2014153145-A2 CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2014-09-25 WO disclosed
EP-2337779-A2 2-OXO-1,2-DIHYDRO-QUINOLINE MODULATORS OF IMMUNE FUNCTION Teva Pharmaceutical Industries Ltd. (IL) 2011-06-29 EP disclosed
WO-2010028015-A2 2-OXO-1,2-DIHYDRO-QUINOLINE MODULATORS OF IMMUNE FUNCTION AUSPEX PHARMACEUTICALS, INC (US) 2010-03-11 WO disclosed